Business & Tech
Fair Lawn Company is Transforming Drug Delivery
Vyteris, coming off a merger Sept. 13, has developed the "smart patch" to apply medicine through the skin
Fair Lawn-based Vyteris, Inc. has been creating enormous chatter in scientific and financial circles with recent developments in technology to deliver drugs through the skin rather than with needles.
Vyteris devotes 27,000 square feet of space off Pollitt Drive to the research, development and manufacturing of what is known as transdermal medication delivery. Raising what many in mainstream society first became aware of with the nicotine patch for smoking addiction to a new level, Vyteris's technology is described as a "smart patch."
On September 13, Vyteris agreed to merge with a privately held company, MediSync, which provides services for product development, clinical trial management, and data management services in the pharmaceutical, biotechnology and medical device industries.
Find out what's happening in Fair Lawn-Saddle Brookfor free with the latest updates from Patch.
The challenges to delivering drug therapy to patients with temporary or chronic illnesses were overcome with technology utilizing electrical charges that help the drugs pass through the protective barrier of the skin, according to the Vyteris website. Vyteris says the advancement of this technology will eventually prove beneficial to patients receiving cardiovascular, diabetes, fertility, growth disorder, migraine, obesity, pain management, and Parkinson's Disease medications–to name just a few–and it will increase the efficiency of the drugs by avoiding the digestive acids in the stomach for those medications taken orally.
Dr. Mark Prausnitz, Professor of Chemical and Biomedical Engineering at the Georgia Institute of Technology and a leader in developing transdermal delivery systems, said in a statement that "Transdermal drug delivery, in addition to doing away with painful needles, can empower patients to better control their medication schedule, improves drug efficacy in many cases, and offers the promise of reduced healthcare costs. The thermal ablation-based transdermal delivery systems may be beneficial to improving the lives of patients around the world."
Find out what's happening in Fair Lawn-Saddle Brookfor free with the latest updates from Patch.
In addition to this month's merger with MediSync, Vyteris optioned an exclusive license from Georgia Tech in August, adding to it's portfolio of over 180 patents.
Haro Hartounian, chief executive officer at Vyteris, said in a statement that, "MediSync provides us with the opportunity to broaden our corporate strategy, bringing both a revenue platform…and execution expertise to more rapidly develop our pipeline products."
